PSCRO November 1, 2019 Articles Abstract Abstract unavailable. Please download related documents below. PSCRO.2019.7e1002 (November 1, 2019) Pranela Rameshwar Download Full Text Download Full Article PDF Download XML DOI: 10.14343/PSCRO.2019.7e1002 Tags: Pranela Rameshwar Continue Reading Previous PostCXCL12-Abundant Reticular (CAR): A Review of the Literature with Relevance to Cancer Stem Cell Survival (2)Next PostStem Cells in Ovarian Cancer and Potential Therapies You Might Also Like Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015 Cancer stem cells and autophagy: Facts and Perspectives July 7, 2014 Securin: A Novel Stem/Cancer Stem Cell Marker January 6, 2019
Enhanced activation of STAT3 in ascites-derived recurrent ovarian tumors: inhibition of cisplatin-induced STAT3 activation reduced tumorigenicity of ovarian cancer by a loss of cancer stem cell-like characteristics February 27, 2015